Effect of serotonin, thromboxane A2, and specific receptor antagonists on vascular smooth muscle cell proliferation

Circulation

Volumn 96, Issue 7, 1997, Pages 2280-2286

  Pakala, Rajbabu ^a   Willerson, James T ^a   Benedict, Claude R ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Cells; Muscle, smooth; Platelets; Restenosis; Serotonin; Thromboxane

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; RIDOGREL; SERGOLEXOLE MALEATE; SEROTONIN; THROMBOXANE A2;

ANIMAL CELL; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL COUNT; CELL PROLIFERATION; DOG; GROWTH REGULATION; MITOGENICITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTENOSIS; THROMBOCYTE AGGREGATION; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR SMOOTH MUSCLE;

EID: 0030825166     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.7.2280     Document Type: Article

References (49)

1. Holmes DR, Vlietstra RE, Smith HC. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol. 1984;53:77C-81C.
2. Serruys PW, Luitjen HE, Beatt KJ. Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon: a quantitative angiographie study in 342 consecutive patients at 1, 2, 3, and 4 months. Circulation. 1988;77:361-371.
3. Liu MW, Roubin OS, King SB III. Restenosis after coronary angioplasty, potential biologic determinants and role of intimai hyperplasia. Circulation. 1989;79:1374-1385.
4. Casscells W. Migration of smooth muscle and endothelial cells: critical events in restenosis. Circulation. 1992;86:723-729.
5. Ross R, Masuda J, Raines EW. Cellular interactions, growth factors, and smooth muscle proliferation in atherogenesis./ln/i N Y AcadSci. 1990;598:102-111.
6. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. / Am Coll Cardiol. 1990;15:1667-1687.
7. Golino P, Piscione F, Benedict CR, Anderson HV, Cappelli-Bigazzi M, Indolfi C, Condorelli M, Chiariello M, Willerson JT. Local effect of serotonin released during coronary angioplasty. N Engl JMed. 1994;330:523-528.
8. Adams PC, Badimon JJ, Badimon L, Chesebro JH, Fuster V. Role of platelets in atherogenesis: relevance to coronary arterial restenosis after angioplasty. Cardiovasc Clin. 1987;18:49-71.
9. Fingerle J, Johnson R, Clowes AW, Majesky MW, Reidy MA. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Nail Acad Sei USA. 19S9;86:8412-8416.
10. Friedman RJ, Stemerman MB, Wenz B, Moore S, Gauldie J, Gent M, Tiell ML, Spaet TH. The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits: smooth muscle cell proliferation and re-endothelialization. J Clin Invest. 1977;60: 1191-1201.
11. Semven K, Magnaldo I, Pouyssegur J. Serotonin stimulates DNA synthesis in fibroblasts acting through 5HT1B receptors coupled to a G.-protein. Nature. 19S8;335:254-256.
12. Takuwa N, Ganz M, Takuwa YM, Sterzel RB, Rasmussen H. Studies of the mitogenic effect of serotonin in rat renal mesangial cells. Am J Pliysiol. 1989;257:F531-F539.
13. Tutton PJM, Barkla DH. Serotonin receptors influencing cell proliferation in the jejunal crypt epithelium and in colonie adenocarcinomas. Anticancer Res. 1986;6:1123-1126.
14. Ishizuka J, Beauchamp RD, Townsend CM Jr, Greeley GH Jr, Thompson JC. Receptor-mediated autocrine growth-stimulatory effect of 5-hydroxytryptamine on cultured human pancreatic carcinoid cells. J Cell Physiol. 1992;150:l-7.
15. Crowley ST, Dempsey EC, Horwitz KB, Horwitz LD. Platelet induced vascular smooth muscle cell proliferation is modulated by the growth amplification factors and adenosine diphosphate. Circulation. 1994;90:1908-1918.
16. Nemecek GM, Coughlin SR, Handley DA, Moskowitz MA. Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc NatlAcad Sei USA. 1986;83:674-678.
17. Vankova M, Grumvald J. Effect of serotonin and 5-hydroxy-indole3-acetic acid on smooth muscle cell proliferation. Med Sei Res. 1987;15:1261-1262.
18. Kavanaugh WM, Williams LT, Ives HE, Coughlin SR. Serotonininduced deoxyribonucleic acid synthesis in vascular smooth muscle cells involves a novel, pertussis toxin-sensitive pathway. Mol Endocrinol. 1988;2:599-605.
19. Araki S, Kawahara Y, Fukuzaki H, Takai Y. Serotonin plays a major role in serum-induced phospholipase C-mediated hydrolysis of phosphoinositides and DNA synthesis in vascular smooth muscle cells. Atherosclerosis. 1990;83:29-34.
20. Lee SR, Wang WW, Moore BJ, Fanburg BL. Dual effect of serotonin on growth of boyine pulmonary artery smooth muscle cells in culture. Circ Res. 1991;68:1362-1368.
21. Kent TA, Jazayeri A, Simard JM. Calcium channels and nifedipine inhibition of serotonin-induced [3H]thymidine incorporation in cultured cerebral smooth muscle cells. J Cereb Blood Flow Metab. 1992;12:139-146.
22. Pakala R, Willerson JT, Benedict CR. Mitogenic effect of serotonin on vascular endothelial cells. Circulation. 1994;90:1919-1926.
23. Sachinidis A, Flesch M, Ko Y, Schror K, Bohm M, Dusing R, Vetter H. Thromboxane A2 and vascular smooth muscle cell proliferation. Hypertension. 1995;26:771-780.
24. Ishimitsu T, Uehara Y, Ishi M, Ikeda T, Matsuoka H, Sugimoto T. Thromboxane and vascular smooth muscle cell growth in genetically hypertensive rats. Hypertension. 1988;12:46-51.
25. Smith EF, Lefer MA, Nicolau KC. Mechanisms of coronary vasoconstriction induced by carbocyclic thromboxane A2. Am J Physiol. 1981;240:H493-H497.
26. Dorn GW, Becker MW, Davis M. Dissociation of the contractile and hypertrophie effects of vasoconstrictor prostanoids in vascular smooth muscle cells. JB/o/ Chem. 1992;267:24897-24905.
27. Hanasaki K, Nakano T, Arita H. Receptor-mediated mitogenic effect of thromboxane A2 in vascular smooth muscle cells. Biochem Phannacol. 1990;40:2535-2542.
28. Nigata T, Uehara Y, Numabe A, Ishimitsu T, Hirawa N, Ikeda T, Matsuoka H, Sugimoto T. Regulatory effect of thromboxane A2 on proliferation of vascular smooth muscle cells from rats. Am J Physiol. 1992;263:H1331-H1338.
29. Cohen ML, Fuller RW, Kurz KD, Parli CJ, Mason NR, Meyers DB, Smallwood JK, Tommey RE. Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067. J Pharmacol Exp Ther. 1988;244:106-112.
30. DeClerck F, Beetens J, de Chaffoy de Courcelles D, Freyne E, Janssen PAJ. R68070: thromboxane A2 synthase inhibition and thromboxane Aj/prostaglandin endoperoxide receptor blockade combined in one molecule, I: biochemical profile in vitro. Thromb Haemost. 1989;61:35-42.
31. Ross R. The pathogenesis of atherosclerosis: an update. N Engl JMed. 1988;314:488-500.
32. Hanley MR. Mitogenic neurotransmitters. Nature. 1989;340:97-98.
33. Humphrey PPA, Hartig P, Hpyer D. A proposed new nomenclature for serotonin receptors. Trends Pharmacol Sei. 1993;14:233-236.
34. DeMey JGR, Uitendaal MP, Boonen HCM, Vrijdag MJJF, Daemen MJAP, Struyker-Boudier HAJ. Acute and long term effects of tissue culture on contractile reactivity in renal arteries of the heart. Circ Res. 1989;65:1125-1135.
35. Bell L, Madri JA. Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells. Circ Res. 1989; 65:1057-1065.
36. Corson MA, Alexander RW, Berk BC. 5-HT2 receptor mRNA is overexpressed in cultured rat aortic smooth muscle cells relative to normal aorta. Am J Pliysiol. 1992;262(CW/ Plysiol 31):C309-C315.
37. Knezewic T, Borg C, Le Brelon GC. Identification of Gq as one of the G-proteins which copurify with human platelet thromboxane Aprostaglandin H, receptors. J Dial Chem. 1993;268:26111-26117.
38. Gordeladze JO, Jorianson PW, Paulssen RH, Paulssen EJ, Gautvik KM. G-proteins: implication for pathophysiology and disease. EnrJ Endocrinol. 1994;131:557-574.
39. Hepler JR, Gilman AG. G proteins. Trends Biochem Sei. 1992;17: 383-387.
40. Sternweis PC, Smrcka AV. Regulation of phospholipase C by G proteins. Trends Biochem Sei. 1992;17:502-505.
41. Shenker A, Goldsmith P, Unson CG, Spiegel AM. The G protein coupled to the TXAPGH, receptor in human platelets is a member of the novel Gq family. J Biol Chem. 1991;266:9309-9313.
42. Offermans S, Laugwitz KL, Spicher'K, Schulz G. G proteins of the G12 family are activated via the thromboxane Ai and thrombin receptors in human platelets. Proc Natl Acad Sei USA. 1994;91: 504-508.
43. Campbell JH, Campbell RG. Culture techniques and their applications to studies of vascular smooth muscle. Clin Sei. 1993;85: 501-513.
44. Schwartz L, Bourassa MG, Lesperance J, Aldridge HE, Kazim F, Salvatori VA, Henderson M, Bonan M, David PR. Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary anaioplasty. N Engl J Med. 1988;318: 1714-1719.
45. Urban P, Buller N, Fox K, Shapiro L, Bayliss J, Rickards A. Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon coronary angioplasty. Br Heart J. 1988:60:485-488.
46. Ellis SG, Roubin GS, Wilentz J, Douglas JS, King SB II. Effect of 18- to 24 hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J. 1989;117: 777-782.
47. Serruys PW, Rutsch W, Heyndrickx GR, Danchin N, Mast EG, Wijns W, Rensing BJ, Vos J, Stibbe J, Coronary Artery Restenosis Prevention on Repeated Thrombo.xane-Antagonism Study Group (CARPORT). Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. Circulation. 1991;84:1568-15SO.
48. Serruys PW, Klein W, Tijssen JPG, Rutsch W, Heyndrickx GR, Emanuelsson H, Ball SG, Decoster O, Schroeder E, Liberman H, Eichhorn E, Willerson JT, Anderson HV, Khaja F, Alexander RW, Baim D, Melkert R, Van Oene JC, Van Gool R. Evaluation of ketanscrin in the prevention of restenosis after percutaneous transluminal coronary angioplasty: a multicenter randomized double-blind placebo-controlled trial. Circulation. 1993;88: 1588-1601.
49. Willerson JT, Yao SK, McNatt J, Benedict CR, Anderson HV, Golino P, Murphree SS, Buja LM. Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury. Proc Natl Acad Sei USA. 1991;88:1062410628.